Coverage
Filings
| Filing | Date |
|---|---|
| INTERIM REPORT FOR Q1 2022/23 | 7 Feb 2023 |
| AMBU CAPITAL MARKETS DAY 2023 | 7 Feb 2023 |
| Decisions of Annual General Meeting of Ambu A/S | 14 Dec 2022 |
| Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities | 29 Nov 2022 |
| NOTICE OF ANNUAL GENERAL MEETING OF AMBU A/S | 18 Nov 2022 |
| ANNUAL RESULTS 2021/22 (EARNINGS RELEASE) | 15 Nov 2022 |
| Annual Report 2021/22 | 15 Nov 2022 |
| Ambu A/S: Financial Calendar |
Danish medical device maker Ambu on Wednesday reported double-digit revenue growth for its 2024/25 fiscal year and launched a new strategy aimed at achieving global leadership in the single-use endoscopy market.
Danish medical device maker Ambu A/S on Wednesday launched a new strategy aimed at achieving global leadership in the single-use endoscopy market as it reported full-year results in line with its guidance.
Danish medical device maker Ambu A/S on Tuesday raised its long-term growth targets as part of a new strategic plan, building on what it called a successful financial turnaround.
Medical device maker Ambu A/S on Friday cut its full-year free cash flow forecast, citing negative impacts from foreign exchange rates and tariff costs, even as it reported solid quarterly growth.
| 30 Sept 2022 |
| Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities | 29 Aug 2022 |
| INTERIM REPORT FOR Q3 2021/22 | 25 Aug 2022 |
| Preliminary results for Q3 2021/22, current trading (July) and launch of cost reduction program. Full-year 2021/22 guidance revised | 3 Aug 2022 |
| Britt Meelby Jensen appointed new CEO of Ambu | 19 May 2022 |